Evaluating elexacaftor/tezacaftor/ivacaftor (ETI; Trikafta™) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): A clinical study protocol - Colin E. Swenson; William R. Hunt; Candela Manfredi; Diana J. Beltran; Jeong S. Hong; Brian R. Davis; Shingo Suzuki; Cristina Barillá; Andras Rab; Cynthia Chico; Joy Dangerfield; Ashleigh Streby; et al. (PLoS ONE, 2025)